Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 03 nov. 2024.APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735